GMP certification for Ayurvedic tablets means more than a certificate on the wall: here is what buyers should verify before placing a bulk order.
GMP certification is the minimum standard a buyer should verify before placing a bulk order for Ayurvedic tablets. It confirms that a manufacturer follows documented processes, maintains hygiene controls and can produce a traceable batch record. For B2B buyers, it reduces the risk of product recalls and regulatory objections in destination markets.
Good Manufacturing Practice in India is defined under Schedule T of the Drugs and Cosmetics Act, 1940. For Ayurvedic medicines, the AYUSH ministry issues GMP certificates to manufacturers who satisfy inspectors on premises layout, raw material storage, production workflow, laboratory testing and documentation. A valid certificate carries a unique number, the issuing state licencing authority and an expiry date.
Schedule T requirements address staff qualifications, batch manufacturing records, in-process controls and finished-product release criteria. When a manufacturer holds a valid AYUSH manufacturing licence alongside the GMP certificate, it signals that the facility is routinely audited, not merely certified once and left unmonitored. Buyers should treat the absence of a current licence as a disqualifying factor, not a minor gap to be explained away.
Raasa Ayurveda holds GMP certificate D-5755/09 and AYUSH manufacturing licence A-4177/2009, covering classical Shastrayoga formulations across thirteen categories including Vati-Gutika tablets, the dosage form most buyers source for finished-product brands. Seventeen years of manufacturing experience means the documentation systems are mature, not newly assembled for the purpose of passing an inspection.
Many buyers assume that a photocopy of a certificate is sufficient due diligence. It is not. A thorough check should cover several areas.
Certificate number and issuing authority: state drug control departments issue these; the number should be verifiable against official records or a site inspection report. Ask whether the certificate can be confirmed directly with the issuing authority.
Scope of the licence: some licences cover only certain dosage forms. A certificate valid for Asava-Arishta does not automatically extend to tablet compression or bhasma preparation. Ask to see the approved product list attached to the licence before assuming your required dosage form is included.
Expiry and renewal status: GMP certificates are not perpetual. Confirm the current validity period and ask whether the last renewal audit raised any observations that required corrective action. A history of prompt corrective actions is a positive indicator, not a cause for concern.
FSSAI registration, where relevant: Raasa Ayurveda holds FSSAI licence 22722647000052, relevant for formulations that may be classified as health supplements in certain markets.
Ask your shortlisted manufacturer to share all three licences together, not each in isolation. A consistent address, name and scope across documents gives confidence that records are well-maintained and that the facility you are contracting with is the facility named on the licence.
A certified manufacturer issues a batch manufacturing record for every production run. This document traces raw material lot numbers, process parameters, in-process test results and the final release decision. As a buyer, you should expect to receive a certificate of analysis with every consignment, showing the tests performed and results against specification.
Standard pharmacopoeial tests for Ayurvedic tablets include loss on drying, ash value, disintegration time, hardness, weight variation and microbial limits. Heavy metal testing is increasingly required by importers, particularly for bhasma-containing formulations. When evaluating a supplier, ask which tests are performed in-house and which are routed to an accredited external laboratory, and request a sample certificate of analysis before committing to a bulk order.
A batch that has passed all release tests and been signed off by a qualified person is significantly different from a batch released on the basis of a visual check only. GMP certification is the mechanism that makes this distinction enforceable and auditable, and the batch record is your evidence that the mechanism was applied.
A brand owner placing a private-label order carries reputational and regulatory risk that goes beyond the immediate transaction. If a product fails a market-surveillance test in an export destination, the brand name on the label faces withdrawal and possible recall, even if the manufacturer was at fault. Insisting on GMP-certified contract manufacturing is the first line of protection.
For buyers working in regulated markets such as the EU, the UK or North America, GMP certification aligned with local standards may be an additional requirement. Indian Schedule T GMP provides the domestic baseline. Export buyers should confirm whether additional documentation, such as a WHO-GMP certificate or a site master file, is expected by the importing regulator. Some buyers also commission their own audit before placing the first significant order.
A useful early step is to request the manufacturer's last GMP renewal inspection report, if they are willing to share it under a non-disclosure agreement. Observations raised during an inspection and the corrective actions taken reveal more about a facility's quality culture than the certificate number alone.
Beyond licence verification, a careful buyer asks: which batch manufacturing records can be shared under a non-disclosure agreement before the first order; what is the sampling and testing protocol for incoming raw materials; how are rejections and deviations documented and resolved; what stability data supports the stated shelf life; and does the manufacturer offer a pre-order sample so the buyer can commission independent testing.
Understanding the answers to these questions before committing to a sourcing agreement saves time and money compared to discovering gaps after production has begun. A manufacturer who answers these questions readily and in detail is demonstrating the transparency that GMP documentation is designed to create.
Raasa Ayurveda offers samples before bulk orders and supplies a certificate of analysis with every consignment from its Kanpur facility. Enquiries about bulk supply of classical tablets, including Vati formulations, are welcome. Reach the team at raasaayurveda@gmail.com or +91 9415128217 to discuss licence documents, sample logistics and sourcing terms.
Schedule T is the annex to the Drugs and Cosmetics Act, 1940 that sets minimum standards for premises, equipment, documentation and personnel for Ayurvedic, Siddha and Unani manufacturing facilities in India. Compliance is a prerequisite for an AYUSH manufacturing licence and GMP certificate from the relevant state drug authority.
Yes, and you should. A reputable GMP-certified manufacturer will share current copies of the GMP certificate, AYUSH manufacturing licence and FSSAI registration on request. Verify that the certificate is in date, issued by the relevant state authority and covers the dosage form you intend to order, not just a related category.
A certificate of analysis for Ayurvedic tablets should include identity of ingredients, loss on drying, total ash, disintegration time, hardness, weight variation and microbial limits as a minimum. Heavy metal results are increasingly expected by importers. The document should carry the batch number, date and an authorised release signature.
Schedule T requires documented incoming material testing and approved supplier lists, so raw material sourcing is within the GMP scope. Ask specifically about the incoming testing protocol for key botanicals and whether the manufacturer maintains certificates of analysis for each raw material lot used in your batch.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.